Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases.

Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V, Franko A.

Radiol Oncol. 2020 Mar 7;54(1):86-95. doi: 10.2478/raon-2020-0011.

2.

5G support for Industrial IoT Applications - Challenges, Solutions, and Research gaps.

Varga P, Peto J, Franko A, Balla D, Haja D, Janky F, Soos G, Ficzere D, Maliosz M, Toka L.

Sensors (Basel). 2020 Feb 4;20(3). pii: E828. doi: 10.3390/s20030828.

3.

Severe lung disease characterized by lymphocytic bronchiolitis, alveolar ductitis, and emphysema (BADE) in industrial machine-manufacturing workers.

Cummings KJ, Stanton ML, Nett RJ, Segal LN, Kreiss K, Abraham JL, Colby TV, Franko AD, Green FHY, Sanyal S, Tallaksen RJ, Wendland D, Bachelder VD, Boylstein RJ, Park JH, Cox-Ganser JM, Virji MA, Crawford JA, Green BJ, LeBouf RF, Blaser MJ, Weissman DN.

Am J Ind Med. 2019 Nov;62(11):927-937. doi: 10.1002/ajim.23038. Epub 2019 Aug 28.

PMID:
31461179
4.

Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells.

Franko A, Hartwig S, Kotzka J, Ruoß M, Nüssler AK, Königsrainer A, Häring HU, Lehr S, Peter A.

Nutrients. 2019 Aug 3;11(8). pii: E1795. doi: 10.3390/nu11081795.

5.

The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma.

Levpuscek K, Goricar K, Kovac V, Dolzan V, Franko A.

Radiol Oncol. 2019 Mar 14;53(2):206-212. doi: 10.2478/raon-2019-0016.

6.

Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment.

Senk B, Goricar K, Kovac V, Dolzan V, Franko A.

Radiol Oncol. 2019 Mar 3;53(1):96-104. doi: 10.2478/raon-2019-0009.

7.

Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes.

Aatsinki SM, Elkhwanky MS, Kummu O, Karpale M, Buler M, Viitala P, Rinne V, Mutikainen M, Tavi P, Franko A, Wiesner RJ, Chambers KT, Finck BN, Hakkola J.

Diabetes. 2019 May;68(5):918-931. doi: 10.2337/db18-1050. Epub 2019 Mar 4.

8.

Augmented contractility of murine femoral arteries in a streptozotocin diabetes model is related to increased phosphorylation of MYPT1.

Lubomirov LT, Gagov H, Schroeter MM, Wiesner RJ, Franko A.

Physiol Rep. 2019 Feb;7(3):e13975. doi: 10.14814/phy2.13975.

9.

Multidrug-resistant Aeromonas hydrophila causing fatal bilateral necrotizing fasciitis in an immunocompromised patient: a case report.

Ugarte-Torres A, Perry S, Franko A, Church DL.

J Med Case Rep. 2018 Nov 1;12(1):326. doi: 10.1186/s13256-018-1854-1.

10.

Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.

Franko A, Merkel D, Kovarova M, Hoene M, Jaghutriz BA, Heni M, Königsrainer A, Papan C, Lehr S, Häring HU, Peter A.

Nutrients. 2018 Sep 17;10(9). pii: E1314. doi: 10.3390/nu10091314.

11.

[The in vitro examination of the effectiveness of antiseptic substances for a surface disinfection of teeth inoculated with Escherichia coli].

Makeeva IM, Franko A, Semenov AM, Byakova SF, Novozhilova NE, Dezhurko-Korol VA.

Stomatologiia (Mosk). 2018;97(4):8-10. doi: 10.17116/stomat2018970418. Russian.

PMID:
30199059
12.

cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation.

Franko A, Kovarova M, Feil S, Feil R, Wagner R, Heni M, Königsrainer A, Ruoß M, Nüssler AK, Weigert C, Häring HU, Lutz SZ, Peter A.

Metabolism. 2018 Nov;88:22-30. doi: 10.1016/j.metabol.2018.09.001. Epub 2018 Sep 6.

13.

hIAPP forms toxic oligomers in plasma.

Rodriguez Camargo DC, Garg D, Buday K, Franko A, Rodriguez Camargo A, Schmidt F, Cox SJ, Suladze S, Haslbeck M, Mideksa YG, Gemmecker G, Aichler M, Mettenleiter G, Schulz M, Walch AK, Hrabě de Angelis M, Feige MJ, Sierra CA, Conrad M, Tripsianes K, Ramamoorthy A, Reif B.

Chem Commun (Camb). 2018 May 24;54(43):5426-5429. doi: 10.1039/c8cc03097a.

14.

Metabolic Maturation during Muscle Stem Cell Differentiation Is Achieved by miR-1/133a-Mediated Inhibition of the Dlk1-Dio3 Mega Gene Cluster.

Wüst S, Dröse S, Heidler J, Wittig I, Klockner I, Franko A, Bonke E, Günther S, Gärtner U, Boettger T, Braun T.

Cell Metab. 2018 May 1;27(5):1026-1039.e6. doi: 10.1016/j.cmet.2018.02.022. Epub 2018 Apr 5.

15.

The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma.

Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V.

Radiol Oncol. 2018 Jan 24;52(1):105-111. doi: 10.2478/raon-2018-0004. eCollection 2018 Mar.

16.

Multiple Thromboembolic Events from a Left Atrial Appendage Occlusion Device.

Prosperi-Porta G, Schnell G, Colbert J, Franko A, Wilton SB, Kuriachan VP.

Can J Cardiol. 2018 Mar;34(3):342.e13-342.e15. doi: 10.1016/j.cjca.2017.12.017. Epub 2017 Dec 27.

PMID:
29475536
17.

Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.

Franko A, Rodriguez Camargo DC, Böddrich A, Garg D, Rodriguez Camargo A, Rathkolb B, Janik D, Aichler M, Feuchtinger A, Neff F, Fuchs H, Wanker EE, Reif B, Häring HU, Peter A, Hrabě de Angelis M.

Sci Rep. 2018 Jan 18;8(1):1116. doi: 10.1038/s41598-017-18807-8.

18.

Impaired Insulin Signaling is Associated with Hepatic Mitochondrial Dysfunction in IR+/--IRS-1+/- Double Heterozygous (IR-IRS1dh) Mice.

Franko A, Kunze A, Böse M, von Kleist-Retzow JC, Paulsson M, Hartmann U, Wiesner RJ.

Int J Mol Sci. 2017 May 30;18(6). pii: E1156. doi: 10.3390/ijms18061156.

19.

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes.

Rodriguez Camargo DC, Tripsianes K, Buday K, Franko A, Göbl C, Hartlmüller C, Sarkar R, Aichler M, Mettenleiter G, Schulz M, Böddrich A, Erck C, Martens H, Walch AK, Madl T, Wanker EE, Conrad M, de Angelis MH, Reif B.

Sci Rep. 2017 Mar 13;7:44041. doi: 10.1038/srep44041.

20.

Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.

Franko A, Neschen S, Rozman J, Rathkolb B, Aichler M, Feuchtinger A, Brachthäuser L, Neff F, Kovarova M, Wolf E, Fuchs H, Häring HU, Peter A, Hrabě de Angelis M.

Mol Metab. 2017 Jan 6;6(3):256-266. doi: 10.1016/j.molmet.2016.12.007. eCollection 2017 Mar.

21.

Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer.

Meyers D, Nixon NA, Franko A, Ng D, Tam VC.

BMJ Case Rep. 2017 Feb 13;2017. pii: bcr2016218107. doi: 10.1136/bcr-2016-218107.

22.

Bezafibrate Improves Insulin Sensitivity and Metabolic Flexibility in STZ-Induced Diabetic Mice.

Franko A, Huypens P, Neschen S, Irmler M, Rozman J, Rathkolb B, Neff F, Prehn C, Dubois G, Baumann M, Massinger R, Gradinger D, Przemeck GK, Repp B, Aichler M, Feuchtinger A, Schommers P, Stöhr O, Sanchez-Lasheras C, Adamski J, Peter A, Prokisch H, Beckers J, Walch AK, Fuchs H, Wolf E, Schubert M, Wiesner RJ, Hrabě de Angelis M.

Diabetes. 2016 Sep;65(9):2540-52. doi: 10.2337/db15-1670. Epub 2016 Jun 9.

23.

Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.

Goričar K, Kovač V, Franko A, Dodič-Fikfak M, Dolžan V.

Dis Markers. 2015;2015:316739. doi: 10.1155/2015/316739. Epub 2015 Sep 16.

24.

Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma.

Kovac V, Dodic-Fikfak M, Arneric N, Dolzan V, Franko A.

Radiol Oncol. 2015 Aug 21;49(3):279-85. doi: 10.1515/raon-2015-0019. eCollection 2015 Sep.

25.
26.

Efficient isolation of pure and functional mitochondria from mouse tissues using automated tissue disruption and enrichment with anti-TOM22 magnetic beads.

Franko A, Baris OR, Bergschneider E, von Toerne C, Hauck SM, Aichler M, Walch AK, Wurst W, Wiesner RJ, Johnston IC, de Angelis MH.

PLoS One. 2013 Dec 12;8(12):e82392. doi: 10.1371/journal.pone.0082392. eCollection 2013.

27.

Liver adapts mitochondrial function to insulin resistant and diabetic states in mice.

Franko A, von Kleist-Retzow JC, Neschen S, Wu M, Schommers P, Böse M, Kunze A, Hartmann U, Sanchez-Lasheras C, Stoehr O, Huntgeburth M, Brodesser S, Irmler M, Beckers J, de Angelis MH, Paulsson M, Schubert M, Wiesner RJ.

J Hepatol. 2014 Apr;60(4):816-23. doi: 10.1016/j.jhep.2013.11.020. Epub 2013 Nov 28.

PMID:
24291365
28.

The influence of gene-gene and gene-environment interactions on the risk of asbestosis.

Franko A, Dolžan V, Arnerić N, Dodič-Fikfak M.

Biomed Res Int. 2013;2013:405743. doi: 10.1155/2013/405743. Epub 2013 Jul 25.

29.

Underestimating underrecognition: the authors' reply.

Franko AD, Wright JR Jr, Trotter MJ.

Am J Clin Pathol. 2013 May;139(5):694. No abstract available.

PMID:
23720870
30.

Underrecognition of pathologist contributions to articles published in a major multidisciplinary medical journal.

Franko AD, Wright JR Jr, Trotter MJ.

Am J Clin Pathol. 2012 Oct;138(4):495-7.

PMID:
23010702
31.

DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.

Erčulj N, Kovač V, Hmeljak J, Franko A, Dodič-Fikfak M, Dolžan V.

J Thorac Oncol. 2012 Oct;7(10):1609-17. doi: 10.1097/JTO.0b013e3182653d31.

32.

Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle.

Franko A, von Kleist-Retzow JC, Böse M, Sanchez-Lasheras C, Brodesser S, Krut O, Kunz WS, Wiedermann D, Hoehn M, Stöhr O, Moll L, Freude S, Krone W, Schubert M, Wiesner RJ.

J Mol Med (Berl). 2012 Oct;90(10):1145-60. doi: 10.1007/s00109-012-0887-y. Epub 2012 Mar 13.

PMID:
22411022
33.

Soluble mesothelin-related peptides levels in patients with malignant mesothelioma.

Franko A, Dolzan V, Kovac V, Arneric N, Dodic-Fikfak M.

Dis Markers. 2012;32(2):123-31. doi: 10.3233/DMA-2011-0866.

34.

Central FoxO3a and FoxO6 expression is down-regulated in obesity induced diabetes but not in aging.

Zemva J, Schilbach K, Stöhr O, Moll L, Franko A, Krone W, Wiesner RJ, Schubert M.

Exp Clin Endocrinol Diabetes. 2012 Jun;120(6):340-50. doi: 10.1055/s-0031-1297970. Epub 2011 Dec 20.

PMID:
22187289
35.

The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.

Erčulj N, Kovač V, Hmeljak J, Franko A, Dodič-Fikfak M, Dolžan V.

Pharmacogenet Genomics. 2012 Jan;22(1):58-68. doi: 10.1097/FPC.0b013e32834e3572.

PMID:
22134350
36.

Inducible nitric oxide synthase genetic polymorphism and risk of asbestosis.

Franko A, Dodič-Fikfak M, Arnerić N, Dolžan V.

J Biomed Biotechnol. 2011;2011:685870. doi: 10.1155/2011/685870. Epub 2011 May 24.

37.

Clinicopathological determinants of vaginal and premalignant-malignant cervico-vaginal polyps of the lower female genital tract.

Fauth C, Franko A, Duan Q, Wood S, Duggan MA.

J Low Genit Tract Dis. 2011 Jul;15(3):210-8. doi: 10.1097/LGT.0b013e31820b7e0f.

PMID:
21427606
38.

WT1 immunoprofiling and comparison of malignant Mullerian mixed tumors of the female genital tract.

Franko A, Magliocco AM, Duan Q, Duggan MA.

Int J Gynecol Pathol. 2010 Sep;29(5):452-8. doi: 10.1097/PGP.0b013e3181d55597.

PMID:
20736771
39.

Manganese and extracellular superoxide dismutase polymorphisms and risk for asbestosis.

Franko A, Dodic-Fikfak M, Arnerić N, Dolzan V.

J Biomed Biotechnol. 2009;2009:493083. doi: 10.1155/2009/493083. Epub 2009 Jul 14.

40.

Asbestosis and catalase genetic polymorphism.

Franko A, Dolzan V, Arnerić N, Dodic-Fikfak M.

Arh Hig Rada Toksikol. 2008 Dec;59(4):233-40. doi: 10.2478/10004-1254-59-2008-1907.

PMID:
19064360
41.

Merkel cell carcinoma arising in the ear canal.

Petković M, Krstulja M, Radic J, Zamolo G, Muhvić D, Lovasic I, Kujundzic M, Franko A.

Int J Surg Pathol. 2008 Jul;16(3):337-40. doi: 10.1177/1066896907312670. Epub 2008 Apr 2.

PMID:
18387993
42.

[Magnetic resonance cholangiopancreatography].

Miletić D, Stimac D, Uravić M, Petranović D, Mazur-Grbac M, Valković P, Franko A.

Lijec Vjesn. 2007 Oct-Nov;129(10-11):336-43. Review. Croatian.

PMID:
18257334
43.

CREB-1alpha is recruited to and mediates upregulation of the cytochrome c promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation.

Franko A, Mayer S, Thiel G, Mercy L, Arnould T, Hornig-Do HT, Wiesner RJ, Goffart S.

Mol Cell Biol. 2008 Apr;28(7):2446-59. doi: 10.1128/MCB.00980-07. Epub 2008 Jan 28.

44.

The influence of genetic polymorphisms of GSTP1 on the development of asbestosis.

Franko A, Dolzan V, Arnerić N, Dodic-Fikfak M.

J Occup Environ Med. 2008 Jan;50(1):7-12. doi: 10.1097/JOM.0b013e31815cbab5.

PMID:
18188076
45.

Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis.

Franko A, Dodic-Fikfak M, Arnerić N, Dolzan V.

J Occup Environ Med. 2007 Jun;49(6):667-71.

PMID:
17563610
46.

Alpha-actinin 4 and BAT1 interaction with the cytochrome c promoter upon skeletal muscle differentiation.

Goffart S, Franko A, Clemen CS, Wiesner RJ.

Curr Genet. 2006 Feb;49(2):125-35. Epub 2005 Dec 6.

PMID:
16331456
47.

Long-term effects of elemental mercury on renal function in miners of the Idrija Mercury Mine.

Franko A, Budihna MV, Dodic-Fikfak M.

Ann Occup Hyg. 2005 Aug;49(6):521-7. Epub 2005 Jun 17.

PMID:
15964879
48.

Critical volume model analysis of lung complication data from different strains of mice.

Stavrev P, Stavreva N, Sharplin J, Fallone BG, Franko A.

Int J Radiat Biol. 2005 Jan;81(1):77-88.

PMID:
15962765
49.

Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells.

Turcotte ML, Parliament M, Franko A, Allalunis-Turner J.

Br J Cancer. 2002 Feb 12;86(4):619-24.

50.

Comparative study on the effect of phosphorylated TCR zeta chain ITAM sequences on early activation events in Jurkat T cells.

Chiţu V, Fajka-Boja R, Tóth GK, Váradi G, Hegedüs Z, Frankó A, Szücs KS, Monostori E.

Peptides. 2001 Dec;22(12):1963-71.

PMID:
11786178

Supplemental Content

Loading ...
Support Center